Keros Therapeutics Inc (KROS)

P/OCF Ratio

-4.61×

TTM · Retrieved:

KROS logo

KROS P/OCF Ratio

Current (TTM)-4.61×
KROS Quarterly P/OCF Ratio (-70.97× → -10.37×)
High-resolution chart · PNG

KROS p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-10.3748×
-61.4095×
-20.2904×
197.8029×
-18.3027×
2.5643×
-13.8791×
-68.7377×
-39.7034×
-44.2037×
-47.0495×
-27.8331×
-38.5777×
-35.3841×
-61.1962×
-39.0692×
-29.4206×
-914.3499×
-70.0846×
-63.999×
-56.1202×
-136.106×
-190.8766×
-71.6824×
-66.5937×
-44.9807×
-32.4398×
-60.3567×
-35.4439×
-70.9725×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.